Alinity m reagents and supplies
Ended Awarded Last action
- Contract number
- 36C25925N0116
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $550,000
Award facts
- Contract value 100% obligated
- $550,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a $550,000 Blanket Purchase Agreement (BPA) call for Alinity M reagents and supplies by Veterans Integrated Service Network (VISN) 19, effective through November 30, 2025. The contract utilizes firm fixed pricing and is issued under the parent GSA Schedule vehicle for In-Vitro Diagnostics, Reagents, and Test (FSS-65-VII). Performance will be conducted at Abbott Molecular's facility in Aurora, Colorado. This award represents a continuation of the company's role as a critical supplier of molecular diagnostic reagents to the Veterans Health Administration, supporting infectious disease testing and clinical diagnostics across the VA healthcare system.
Abbott Molecular's award under VISN 19 reflects its established position as a leading provider of diagnostic equipment and reagent supplies to federal healthcare agencies. The company maintains multiple indefinite delivery vehicles totaling over $30 million across various VISNs, including existing BPA arrangements with VISN 19 valued at $3.2 million. This contract carries no small business set-aside designation, consistent with Abbott Molecular's status as a large, established medical technology corporation. The Alinity M reagent supplies support the VA's molecular diagnostic infrastructure for testing infectious diseases including COVID-19, HIV, and hepatitis C, enabling consistent healthcare delivery capabilities across the veterans' healthcare system.
Quick answers
Who was awarded contract 36C25925N0116?
36C25925N0116 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on December 1, 2024.
How much is contract 36C25925N0116 worth?
The government has obligated $550,000 on 36C25925N0116.
Is contract 36C25925N0116 an order under another contract?
Yes. 36C25925N0116 is a BPA call under V797D40222-36C25922A0005, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25925N0116 competed?
The extent of competition for 36C25925N0116 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award